{"filing":{"accession_number":"0001493152-26-036268","cik":"0001716947","ticker":"ENSCW","company_name":"Ensysce Biosciences, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-05","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226036268/form8-k.htm"},"events":[{"id":25777,"run_id":23397,"accession_number":"0001493152-26-036268","anchor_item_number":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"summary":"The filing discloses the completion of a material acquisition of Cy Biopharma, Inc. by Ensysce Biosciences on August 5, 2026, structured as a stock-for-stock merger pursuant to an Agreement and Plan of Merger. The transaction involves issuance of 282,122 shares of Series C Preferred Stock (convertible into 282.1 million common shares) to Cy's equityholders, concurrent with a $43 million private placement financing. This is a classic M\u0026A activity disclosure under Item 1.01, representing a significant change of control and capital transaction material to investors.","company_name":"Ensysce Biosciences, Inc.","ticker":"ENSCW","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":26696,"accession_number":"0001493152-26-036268","item_number":null,"item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.98,"reasoning":"The filing discloses the completion of a material acquisition of Cy Biopharma, Inc. by Ensysce Biosciences on August 5, 2026, structured as a stock-for-stock merger pursuant to an Agreement and Plan of Merger. The transaction involves issuance of 282,122 shares of Series C Preferred Stock (convertible into 282.1 million common shares) to Cy's equityholders, concurrent with a $43 million private placement financing. This is a classic M\u0026A activity disclosure under Item 1.01, representing a significant change of control and capital transaction material to investors.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:33:15.317212+00:00","company_name":"Ensysce Biosciences, Inc.","ticker":"ENSCW","filing_date":"2026-08-06"}]}